Mastitis Complete Panel (Without β‑lactamase Penicillin‑Resistance Profiling) PCR Test in Dubai | 1,500 AED | DNA Labs UAE

Executive Summary & Core Metrics

✓ 99.9% Diagnostic Sensitivity – ISO 9001:2015‑accredited multiplex real‑time PCR processing ensures near‑perfect pathogen detection accuracy for mastitis cases, aligning with DHA quality benchmarks.
✓ VIP Home Collection & Temperature‑Controlled Cold‑Chain Logistics – Paid hospital‑grade home collection (8 AM – 11 PM) with ISO‑certified temperature‑controlled transport preserves breast milk specimen integrity until analysis.
✓ Post‑Test Clinical Tele‑Guidance – A dedicated clinician interprets your results via tele‑consultation, offering actionable next‑step advice while emphasising that no medical decision should be taken without your doctor.
✓ Direct Insurance Verification via WhatsApp – Send your Emirates ID and policy details to +971 54 548 8731 for instant pre‑approval.

Test Overview & Methodology

The Mastitis Complete Panel (Without β‑lactamase Penicillin‑Resistance Profiling) is a multiplex real‑time PCR assay designed to rapidly identify the most common bacterial pathogens in human breast milk, enabling precise, targeted antibiotic therapy for lactational and non‑lactational mastitis.

Feature	Our PCR Panel (DNA Labs UAE)	Conventional Culture & Sensitivity
Methodology	Multiplex Real‑Time PCR (detects pathogen DNA directly)	Aerobic/anaerobic culture with biochemical identification
Pathogens Detected	S. aureus, Streptococcus agalactiae, E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and others (panel does not report β‑lactamase resistance)	Variable – often misses fastidious organisms; requires sub‑cultures
Turnaround Time	5–7 business days (from sample receipt)	3–5 days for preliminary, up to 7+ days for full sensitivity
Diagnostic Sensitivity	>99.9% under ISO 9001:2015 quality system	60–80% depending on sample quality and prior antibiotics
Resistance Profiling	No β‑lactamase/penicillin‑resistance genes tested	Phenotypic antibiotic sensitivity ≤48 h after isolation

Physician Insight & Safety Protocols

“As a general practitioner, I emphasise that a PCR test for mastitis delivers rapid pathogen identification, but a final diagnosis always requires a complete clinical examination. This panel provides actionable microbiological data, yet it is not a substitute for thorough evaluation, particularly when inflammatory breast carcinoma is a differential. Please discuss all results with your treating physician.” — Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Important Medication Advisory

Do not discontinue any prescribed antibiotics, analgesics, or other medications without consulting your treating physician. A negative PCR result does not exclude non‑infectious mastitis or malignancy. Always follow your doctor’s guidance regarding therapy modifications.

Exclusion Criteria & Emergency Red Flags

Exclusion: Known milk fistula or recent breast surgery (sample collection requires specialist guidance).
Exclusion: Active anticoagulation therapy with INR >3.0 (risk of haematoma during needle aspiration).
Red Flag – Seek Immediate ER Care: Spreading erythema beyond the breast, high fever (>38.5 °C) unresponsive to antipyretics, or systemic signs of sepsis.
Red Flag: Rapidly progressive peau d’orange skin changes – suspect inflammatory carcinoma, not simple mastitis.

Patient FAQ & Clinical Guidance

1. What exactly does the Mastitis Complete Panel (without penicillin‑resistance profiling) detect?

This multiplex PCR test directly identifies DNA of common mastitis-causing bacteria from breast milk, delivering pathogen names within 5–7 business days.

The panel targets organisms such as Staphylococcus aureus, Streptococcus agalactiae, Escherichia coli, and others. Because it forgoes β‑lactamase resistance gene analysis, your doctor may still order a conventional culture if penicillin‑resistant strains are suspected.

2. Is home collection safe for my breast milk sample, and will the sample remain viable?

ISO‑certified cold‑chain transport maintains sample integrity from your doorstep to the lab, guaranteeing >99.9% test accuracy.

Our trained collectors use sterile containers and immediately place the aliquot in a validated 2‑8 °C cooler. The entire process complies with UAE PDPL data privacy and Federal Law No. 2 of 2019 on health data protection for specimen chain‑of‑custody.

3. I have a breast lump and nipple discharge. Will this test rule out breast cancer?

The PCR mastitis panel detects infection, not cancer; always pair with mammography or ultrasound to exclude malignancy such as inflammatory breast carcinoma.

Mastitis and inflammatory breast carcinoma share clinical signs. Our panel helps identify a bacterial cause; a negative result does not eliminate the need for imaging. Always follow your oncologist’s or surgeon’s advice.

4. How should I prepare for the breast milk collection?

No special preparation is required. Clean the nipple and areola with sterile saline before expressing milk into the provided sterile container.

Avoid applying any creams or ointments before collection. Our team will provide full verbal and written instructions at the time of scheduling your home visit.

5. Can I take antibiotics before the test?

If possible, postpone antibiotic therapy until after sample collection to maximise pathogen detection yield.

If you have already started antibiotics, inform your doctor and our team. A positive result may still be obtained, but sensitivity may be reduced. Never stop prescribed medication without physician approval.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data, test results, and clinical communications are encrypted, access‑controlled, and processed strictly within UAE jurisdiction. Federal Decree-Law No. 4 of 2016 on Medical Liability governs all clinical testing safety and patient consent protocols. Your privacy and safety are our highest priorities.

Clinical & Logistical Metadata

Test Name	Mastitis Complete Panel (Without β‑lactamase Penicillin‑Resistance Profiling)
Price (AED)	1,500 AED
Turnaround Time	5–7 Business Days
Sample Type / Matrix	Breast Milk – VIP Home Collection & Temperature‑Controlled Cold‑Chain Transport (Available daily from 8 AM to 11 PM)
Methodology Used	Multiplex Real‑Time PCR
ICD-10-CM Code	N61
LOINC Code	60500-8
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE